Magnitude of a conformational change in the glycine receptor beta1-beta2 loop is correlated with agonist efficacy

Stephan A Pless1, Joseph W Lynch

  • 1Queensland Brain Institute and School of Biomedical Sciences, University of Queensland, Brisbane QLD 4072, Australia.

Insights

Agonist efficacy in Cys-loop receptors depends on reaching a pre-open state. This study reveals a specific conformational change in the alpha1-glycine receptor

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biophysics

Background:

  • Cys-loop ion channel receptor efficacy is determined by the rate of isomerization to a pre-open flip state.
  • The shut-open reaction is similar for both low and high efficacy agonists once the flip state is achieved.

Purpose of the Study:

  • To identify the conformational change linked to the closed-flip transition in the alpha1-glycine receptor.
  • To compare ligand-binding domain conformational changes induced by agonists of varying affinities and efficacies.

Main Methods:

  • Utilized voltage-clamp fluorometry to probe receptor structure.
  • Introduced cysteines and labeled them with environmentally sensitive fluorophores.
  • Inferred structural rearrangements from ligand-induced fluorescence changes.

Main Results:

  • Agonist affinity and efficacy inversely correlated with fluorescence changes in ligand-binding domain loops D and E.
  • Agonist affinity and efficacy directly correlated with fluorescence changes near the transmembrane domain interface (A52C).
  • Fluorescence signal magnitude at A52C is proposed to be proportional to the agonist affinity increase from closed to flip states.

Conclusions:

  • A closed-flip conformational change occurs in the microenvironment of Ala-52 in the alpha1-glycine receptor.
  • The magnitude of this conformational change is proportional to the agonist affinity increase between closed and flip states.
  • Specific regions of the ligand-binding domain undergo conformational changes that influence receptor efficacy.

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...